Health Care & Life Sciences » Medical Equipment & Supplies | Second Sight Medical Products Inc.

Second Sight Medical Products Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
8,674.20
34,619.00
15,960.00
10,875.00
7,839.00
4,471
Total Accounts Receivable
468.60
707.60
1,501.00
274.00
1,831.00
504
Inventories
2,346.80
5,722.00
8,209.00
3,416.00
2,700.00
3,250
Other Current Assets
298.20
927.60
1,094.00
717.00
795.00
1,395
Total Current Assets
11,787.80
41,976.20
26,764.00
15,282.00
13,165.00
9,620
Net Property, Plant & Equipment
723.50
1,004.60
1,432.00
1,489.00
1,299.00
1,025
Long-Term Note Receivable
587.50
171.40
5.00
2.00
-
-
Other Assets
162.10
88.60
49.00
39.00
33.00
37
Total Assets
13,261.00
43,240.90
28,250.00
16,812.00
14,497.00
10,682
Accounts Payable
314.30
513.10
710.00
1,156.00
752.00
Other Current Liabilities
2,369.10
7,938.10
7,272.00
4,506.00
5,863.00
Total Current Liabilities
2,683.40
8,451.20
7,982.00
5,662.00
6,615.00
Long-Term Debt
17,487.00
-
-
-
-
Other Liabilities
1,724.10
-
-
-
-
Total Liabilities
21,894.50
8,451.20
7,982.00
5,662.00
6,615.00
Common Equity (Total)
8,633.50
34,789.70
20,268.00
11,150.00
7,882.00
Total Shareholders' Equity
8,633.50
34,789.70
20,268.00
11,150.00
7,882.00
Total Equity
8,633.50
34,789.70
20,268.00
11,150.00
7,882.00
Liabilities & Shareholders' Equity
13,261.00
43,240.90
28,250.00
16,812.00
14,497.00

About Second Sight Medical Products

View Profile
Address
12744 San Fernando Road
Sylmar California 91342
United States
Employees -
Website http://www.secondsight.com
Updated 07/08/2019
Second Sight Medical Products, Inc. develops, manufactures and markets prosthetic devices. Its product the Argus II System, treats outer retinal degenerations and employs electrical stimulation to bypass degenerated photoreceptor cells and to stimulate remaining viable retinal cells thereby inducing visual perception in blind individuals. The firm's system works by converting video images captured by a miniature camera housed in a patient's glasses into a series of small electrical pulses that are transmitted wirelessly to an array of electrodes that are implanted on the surface of the retina.